Phathom Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • Phathom Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $9.9M, a 29.6% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $368M, a 206% increase from 2022.
  • Phathom Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $120M, a 169% increase from 2021.
  • Phathom Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $44.7M, a 60.9% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $368M +$248M +206% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-06-14
2022 $120M +$75.3M +169% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-06-14
2021 $44.7M -$69.8M -60.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $114M -$190M -62.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $305M +$303M +15917% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $1.9M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.